Q1 sales grew +12% (v: +5.9%; p: +3.5%) to €13,244m and the gross profit margin rose from 57.5% to 59.6%. EBITDA went up +15% to €3,846m and net income attributable to shareholders strongly increased +38% to 2,083m. Operating CF (-36% to €841m) does not reflect the stronger operating performance, which was burdened by higher NWC outflow (€-2,87m after €-2,228m) and a significantly lower positive contribution from discontinued activities (€15m after €770m). I
27 Apr 2017
Covestro is fun, but on a reduced stake
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Covestro is fun, but on a reduced stake
Bayer AG (BAYN:WBO) | 0 0 0.5% | Mkt Cap: 80,975m
- Published:
27 Apr 2017 -
Author:
Martin Schnee -
Pages:
3
Q1 sales grew +12% (v: +5.9%; p: +3.5%) to €13,244m and the gross profit margin rose from 57.5% to 59.6%. EBITDA went up +15% to €3,846m and net income attributable to shareholders strongly increased +38% to 2,083m. Operating CF (-36% to €841m) does not reflect the stronger operating performance, which was burdened by higher NWC outflow (€-2,87m after €-2,228m) and a significantly lower positive contribution from discontinued activities (€15m after €770m). I